Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,193 | 96 | 68.6% |
| Debt forgiveness | $978.00 | 1 | 30.6% |
| Education | $26.62 | 4 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Johnson & Johnson Health Care Systems Inc. | $978.00 | 1 | $0 (2024) |
| Amgen Inc. | $702.68 | 30 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $340.28 | 18 | $0 (2019) |
| Arbor Pharmaceuticals, Inc. | $169.59 | 12 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $167.34 | 4 | $0 (2019) |
| Esperion Therapeutics, Inc. | $137.18 | 3 | $0 (2021) |
| Lilly USA, LLC | $128.43 | 2 | $0 (2017) |
| DePuy Synthes Sales Inc. | $106.38 | 1 | $0 (2018) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $106.16 | 8 | $0 (2018) |
| Lundbeck LLC | $71.36 | 5 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $978.00 | 1 | Johnson & Johnson Health Care Systems Inc. ($978.00) |
| 2023 | $44.35 | 2 | Azurity Pharmaceuticals, Inc. ($44.35) |
| 2022 | $73.50 | 3 | Zimmer Biomet Holdings, Inc. ($29.72) |
| 2021 | $95.53 | 5 | Amgen Inc. ($39.80) |
| 2020 | $309.58 | 13 | Esperion Therapeutics, Inc. ($115.42) |
| 2019 | $308.89 | 19 | SANOFI-AVENTIS U.S. LLC ($96.60) |
| 2018 | $562.50 | 23 | Amgen Inc. ($220.22) |
| 2017 | $825.08 | 35 | Amgen Inc. ($261.61) |
All Payment Transactions
101 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/13/2024 | Johnson & Johnson Health Care Systems Inc. | — | Debt forgiveness | In-kind items and services | $978.00 | General |
| 12/13/2023 | Azurity Pharmaceuticals, Inc. | Edarbi (Drug) | Food and Beverage | Cash or cash equivalent | $22.94 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/10/2023 | Azurity Pharmaceuticals, Inc. | Adthyza (Drug) | Food and Beverage | Cash or cash equivalent | $21.41 | General |
| Category: Endocrinology | ||||||
| 10/04/2022 | Zimmer Biomet Holdings, Inc. | Gel-One Cross-linked Hyaluronate (Device) | Food and Beverage | In-kind items and services | $29.72 | General |
| Category: Knees | ||||||
| 08/05/2022 | Arbor Pharmaceuticals, Inc. | Edarbi (Drug) | Food and Beverage | In-kind items and services | $18.90 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/28/2022 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $24.88 | General |
| Category: Inflammation | ||||||
| 06/02/2021 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $19.90 | General |
| Category: Cardiology | ||||||
| 05/04/2021 | ARBOR PHARMACEUTICALS, INC. | Edarbi (Drug) | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/26/2021 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $19.90 | General |
| Category: Inflammation | ||||||
| 02/10/2021 | HeartFlow, Inc. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $19.23 | General |
| Category: Coronary | ||||||
| 01/14/2021 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $21.76 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 12/16/2020 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: Inflammation | ||||||
| 12/07/2020 | Esperion Therapeutics, Inc. | NEXLIZET (Drug), NEXLETOL | Food and Beverage | In-kind items and services | $92.01 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/23/2020 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $22.32 | General |
| Category: Cardiology | ||||||
| 11/18/2020 | Arbor Pharmaceuticals, Inc. | Edarbi (Drug) | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/26/2020 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $23.41 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 09/16/2020 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, JANUMET | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/10/2020 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $21.55 | General |
| Category: Cardiology | ||||||
| 08/25/2020 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $22.79 | General |
| Category: Cardiology | ||||||
| 08/03/2020 | PFIZER INC. | CELEBREX (Drug), FLECTOR | Food and Beverage | In-kind items and services | $17.96 | General |
| Category: INFLAMMATION;ONCOLOGY;PAIN | ||||||
| 07/17/2020 | Bardy Diagnostics, Inc. | Carnation Ambulatory Monitor (Device) | Food and Beverage | Cash or cash equivalent | $10.00 | General |
| Category: Cardiac Arrhythmia Monitoring | ||||||
| 03/05/2020 | Lundbeck LLC | BRINTELLIX (Drug) | Food and Beverage | Cash or cash equivalent | $15.83 | General |
| Category: PSYCHIATRY | ||||||
| 02/05/2020 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $22.22 | General |
| Category: Neuroscience | ||||||
| 01/16/2020 | Lundbeck LLC | BRINTELLIX (Drug) | Food and Beverage | Cash or cash equivalent | $13.26 | General |
| Category: PSYCHIATRY | ||||||
| 11/22/2019 | SANOFI-AVENTIS U.S. LLC | PRALUENT (Drug) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 2 | 60 | 277 | $48,700 | $20,104 |
| 2021 | 2 | 84 | 356 | $63,792 | $27,434 |
| 2020 | 2 | 77 | 335 | $63,412 | $22,416 |
All Medicare Procedures & Services
6 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 30 | 155 | $31,620 | $12,594 | 39.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 30 | 122 | $17,080 | $7,510 | 44.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 46 | 218 | $44,472 | $18,601 | 41.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 38 | 138 | $19,320 | $8,833 | 45.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 46 | 258 | $52,632 | $18,320 | 34.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 31 | 77 | $10,780 | $4,096 | 38.0% |
About Dr. Frederick Brown, M.D
Dr. Frederick Brown, M.D is a Sports Medicine healthcare provider based in Missouri City, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1609955350.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Frederick Brown, M.D has received a total of $3,197 in payments from pharmaceutical and medical device companies, with $978.00 received in 2024. These payments were reported across 101 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($2,193).
As a Medicare-enrolled provider, Brown has provided services to 221 Medicare beneficiaries, totaling 968 services with total Medicare billing of $69,954. Data is available for 3 years (2020–2022), covering 6 distinct procedure/service records.
Practice Information
- Specialty Sports Medicine
- Other Specialties Family Medicine
- Location Missouri City, TX
- Active Since 11/03/2006
- Last Updated 05/04/2011
- Taxonomy Code 207QS0010X
- Entity Type Individual
- NPI Number 1609955350
Products in Payments
- PRALUENT (Drug) $340.28
- Repatha (Biological) $337.89
- Prolia (Biological) $219.58
- FARXIGA (Drug) $167.34
- Edarbi (Drug) $127.77
- TRULICITY (Drug) $115.44
- MONOVISC (Device) $106.38
- NEXLIZET (Drug) $92.01
- BRINTELLIX (Drug) $71.36
- CYCLOSET (Drug) $69.14
- Edarbyclor (Drug) $64.76
- Otezla (Drug) $63.06
- Aimovig (Biological) $55.53
- NEXLETOL (Drug) $45.17
- XIFAXANIBSD (Drug) $40.94
- JARDIANCE (Drug) $30.94
- Gel-One Cross-linked Hyaluronate (Device) $29.72
- Adthyza (Drug) $21.41
- FFRct (Device) $19.23
- PRALUENT (Biological) $19.14
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.